Clinical trial
Autologous Transplant for Multiple Myeloma
NCT00177047 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00177047 |
|---|---|
| Title | Autologous Transplant for Multiple Myeloma |
| Official title | Autologous Transplantation for Multiple Myeloma |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | Stem Cell Transplant, Cyclophosphamide + Mesna, Melphalan, Granulocyte-colony stimulating factor |
| Enrollment | 363 |
| Start date | Apr 20, 2004 |
| Primary completion | Aug 1, 2020 |
| Completion | Aug 1, 2020 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 9, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: